SARS-CoV-2-related Multisystem Inflammatory Syndrome in Adults

  • Antonio Martins Infectious Diseases Intensive Care Unit, Infectious Diseases Department, Centro Hospitalar Universitário de São João, Porto, Portugal; Department of Medicine, Faculdade de Medicina da Universidade do Porto, Porto, Portugal
  • Sílvia Policarpo Infectious Diseases Intensive Care Unit, Infectious Diseases Department, Centro Hospitalar Universitário de São João, Porto, Portugal; Department of Medicine, Faculdade de Medicina da Universidade do Porto, Porto, Portugal
  • André Silva Pinto Infectious Diseases Intensive Care Unit, Infectious Diseases Department, Centro Hospitalar Universitário de São João, Porto, Portugal; Department of Medicine, Faculdade de Medicina da Universidade do Porto, Porto, Portugal; Nephrology and Infectious Diseases R&D, i3S – Instituto de Investigação e Inovação em Saúde da Universidade do Porto, Porto, Portugal
  • Ana Sofia Santos Infectious Diseases Intensive Care Unit, Infectious Diseases Department, Centro Hospitalar Universitário de São João, Porto, Portugal; Department of Medicine, Faculdade de Medicina da Universidade do Porto, Porto, Portugal
  • Paulo Figueiredo Infectious Diseases Intensive Care Unit, Infectious Diseases Department, Centro Hospitalar Universitário de São João, Porto, Portugal; Department of Medicine, Faculdade de Medicina da Universidade do Porto, Porto, Portugal
  • António Sarmento Infectious Diseases Intensive Care Unit, Infectious Diseases Department, Centro Hospitalar Universitário de São João, Porto, Portugal; Department of Medicine, Faculdade de Medicina da Universidade do Porto, Porto, Portugal; Nephrology and Infectious Diseases R&D, i3S – Instituto de Investigação e Inovação em Saúde da Universidade do Porto, Porto, Portugal
  • Lurdes Santos Infectious Diseases Intensive Care Unit, Infectious Diseases Department, Centro Hospitalar Universitário de São João, Porto, Portugal; Department of Medicine, Faculdade de Medicina da Universidade do Porto, Porto, Portugal; Nephrology and Infectious Diseases R&D, i3S – Instituto de Investigação e Inovação em Saúde da Universidade do Porto, Porto, Portugal
DOI: https://doi.org/10.12890/2021_003025

Keywords

SARS-CoV-2, multisystem inflammatory syndrome, adult patients

Abstract

Adults infected with SARS-CoV-2 may develop a multisystem inflammatory syndrome (MIS-A) characterized by elevated inflammatory markers and multisystem organ involvement. We report the case of a patient who presented with fever and vomiting at hospital admission. He tested positive for SARS-CoV-2 infection and blood tests showed elevated inflammatory markers. The patient developed acute cardiac dysfunction and shock in less than 24 hours and the echocardiogram revealed an LVEF of 30%. He was discharged 3 weeks later fully recovered. MIS-A should be considered if a compatible syndrome is observed in patients with evidence of SARS-CoV-2 infection by PCR test or serology.

VIEW THE ENTIRE ARTICLE

References

  • Centers for Disease Control and Prevention. Information for healthcare providers about multisystem inflammatory syndrome in children (MIS-C). Available from: https://www.cdc.gov/mis-c/hcp/ (accessed 10 Oct 2021).
  • Centers for Disease Control and Prevention. Multisystem inflammatory syndrome in adults (MIS-A). Available from: https://www.cdc.gov/mis-c/mis-a.html (accessed 10 Oct 2021).
  • Morris SB, Schwartz NG, Patel P, Abbo L, Beauchamps L, Balan S, et al. Case series of multisystem inflammatory syndrome in adults associated with SARS-CoV-2 infection - United Kingdom and United States, March-August 2020. MMWR Morb Mortal Wkly Rep 2020;69(40):1450–1456. doi:10.15585/mmwr.mm6940e1.
  • Bastug A, Aslaner H, Bilir YA, Kemirtlek N, Gursoy FM, Bastug S, et al. Multiple system inflammatory syndrome associated with SARS-CoV-2 infection in an adult and an adolescent. Rheumatol Int 2021;41:993–1008. doi:10.1007/s00296-021-04843-1.
  • Chau VQ, Giustino G, Mahmood K, Oliveros E, Neibart E, Oloomi M, et al. Cardiogenic shock and hyperinflammatory syndrome in young males with COVID-19.Circ Heart Fail 2020;13(10):e007485. doi:10.1161/CIRCHEARTFAILURE.120.007485.
  • Hékimian G, Kerneis M, Zeitouni M, Cohen-Aubart F, Chommeloux J, Bréchot N, et al. COVID-19 acute myocarditis and multisystem inflammatory syndrome in adult intensive and cardiac care units. Chest 2020;159(2):657–662. doi:10.1016/j.chest.2020.08.2099.
  • Henderson LA, Canna SW, Friedman KG, Gorelik M, Lapidus SK, Bassiri H, et al. American College of Rheumatology clinical guidance for multisystem inflammatory syndrome in children associated with SARS-CoV-2 and hyperinflammation in pediatric COVID-19: version 2. Arthritis Rheumatol 2021;73(4):e13–29. doi:10.1002/art.41616.

    • Published: 2021-11-26

    Issue: 2021: Vol 8 No 11 (view)

    Section: Articles

    How to cite:
    1.
    Martins A, Policarpo S, Silva Pinto A, Santos AS, Figueiredo P, Sarmento A, Santos L. SARS-CoV-2-related Multisystem Inflammatory Syndrome in Adults . EJCRIM 2021;8 doi:10.12890/2021_003025.

    Most read articles by the same author(s)